During the COVID-19 pandemic, the government extended much-needed flexibilities surrounding telehealth to facilitate access to care. Many of these flexibilities were lifesaving. This included allowing the prescription of controlled substances via telehealth to treat substance use disorders and psychiatric conditions. Background Prior to the pandemic, in most instances, a patient required at least one in-person […]
